56 | AzoxymethaneIBA
01/2022
-
02/2002 |
39 | Drinking WaterIBA
01/2019
-
05/2002 |
32 | sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2022
-
10/2003 |
31 | Dextrans (Dextran)FDA Link
01/2022
-
10/2003 |
30 | Proteins (Proteins, Gene)FDA Link
01/2022
-
09/2002 |
19 | beta CateninIBA
07/2010
-
09/2002 |
18 | Dextran SulfateIBA
01/2021
-
02/2005 |
16 | EnzymesIBA
11/2021
-
01/2001 |
15 | AntioxidantsIBA
03/2016
-
01/2001 |
13 | CarcinogensIBA
05/2021
-
01/2001 |
13 | Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2018
-
02/2002 |
12 | CytokinesIBA
05/2022
-
02/2005 |
12 | fucoxanthinIBA
01/2022
-
11/2004 |
12 | Diethylnitrosamine (N-Nitrosodiethylamine)IBA
08/2017
-
01/2004 |
10 | Messenger RNA (mRNA)IBA
06/2017
-
02/2006 |
9 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022
-
10/2003 |
9 | Biomarkers (Surrogate Marker)IBA
11/2021
-
10/2003 |
9 | TeaIBA
04/2017
-
05/2008 |
8 | Carotenoids (Carotene)IBA
12/2021
-
11/2004 |
8 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2014
-
11/2003 |
8 | FlavonoidsIBA
01/2012
-
01/2001 |
7 | AdipokinesIBA
03/2016
-
05/2008 |
7 | Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2014
-
04/2003 |
7 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2012
-
01/2003 |
7 | auraptenIBA
02/2010
-
01/2004 |
7 | PPAR gammaIBA
05/2007
-
04/2003 |
6 | LigandsIBA
12/2021
-
04/2003 |
6 | Biological ProductsIBA
11/2021
-
01/2008 |
6 | Dinoprostone (PGE2)FDA Link
01/2021
-
01/2004 |
6 | LipidsIBA
07/2017
-
06/2004 |
6 | CateninsIBA
06/2017
-
06/2011 |
6 | Branched-Chain Amino AcidsIBA
03/2017
-
05/2009 |
6 | Insulin (Novolin)FDA Link
01/2015
-
05/2004 |
5 | PhytochemicalsIBA
04/2017
-
01/2001 |
5 | Pharmaceutical PreparationsIBA
04/2017
-
07/2004 |
5 | pitavastatin (itavastatin)FDA Link
07/2014
-
11/2007 |
5 | SilymarinIBA
10/2011
-
01/2002 |
5 | nobiletinIBA
01/2011
-
01/2004 |
5 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2007
-
06/2004 |
5 | CyclinsIBA
02/2007
-
04/2003 |
5 | alpha-Linolenic Acid (Linolenic Acid)IBA
11/2006
-
02/2002 |
4 | fucoxanthinolIBA
05/2021
-
07/2017 |
4 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021
-
01/2013 |
4 | (2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
06/2017
-
06/2004 |
4 | astaxanthine (astaxanthin)IBA
03/2016
-
08/2011 |
4 | Insulin-Like PeptidesIBA
05/2014
-
09/2008 |
4 | IGF Type 1 Receptor (IGF 1 Receptor)IBA
05/2014
-
05/2009 |
4 | SesquiterpenesIBA
03/2013
-
10/2003 |
4 | Interleukin-6 (Interleukin 6)IBA
03/2013
-
01/2011 |
4 | Glutathione Transferase (Glutathione S-Transferase)IBA
01/2013
-
01/2003 |
4 | Prostaglandins EIBA
08/2011
-
05/2002 |
4 | benzocycloheptapyridineIBA
01/2011
-
01/2005 |
4 | 2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2011
-
01/2005 |
4 | LeptinIBA
02/2010
-
05/2004 |
4 | DNA (Deoxyribonucleic Acid)IBA
05/2007
-
01/2001 |
4 | 3-nitrotyrosineIBA
06/2006
-
09/2004 |
3 | nitrosobis(2-oxopropyl)amine (NBOP)IBA
05/2021
-
06/2004 |
3 | 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
06/2017
-
01/2011 |
3 | platelet-derived growth factor C (PDGF-C)IBA
03/2017
-
09/2012 |